In this issue:
Once-weekly insulin for type 2 diabetes
CV outcomes with ertugliflozin in type 2 diabetes
SGLT-2 inhibitors and MACE risk
Balanced crystalloids vs. saline in adult DKA
Empagliflozin: clinical events in type 2 diabetes and atherosclerotic CV disease
Canagliflozin and anaemia in type 2 diabetes and chronic kidney disease
Antibody response to SARS-CoV-2 antigens in diabetics
White rice intake increases incident diabetes
Replacing red/processed meat with other protein sources, and type 2 diabetes risk
Please login below to download this issue (PDF)